Clinicians should strongly consider prescribing or co-prescribing naloxone to certain patients at risk for opioid overdose, and educating them about its use, according to guidance released today by the Department of Health and Human Services. For example, the recommendation includes patients prescribed opioids who are receiving them at a dosage of 50 morphine milligram equivalents per day or greater; have respiratory conditions such as chronic obstructive pulmonary disease or obstructive sleep apnea; have been prescribed benzodiazepines; or have a substance use disorder, excessive alcohol use or mental health disorder. “This new guidance reflects our commitment to ensuring those who need overdose-reversing drugs have them and provides practical steps that clinicians, patients, and the public can take to reduce the risk of an overdose,” said HHS Secretary Alex Azar.

Related News Articles

Chairperson's File
During Mental Health Month, let’s all remember that caring for the whole person improves health and saves lives.
Headline
The Health Resources and Services Administration yesterday awarded 120 organizations, including hospitals, $200,000 each to develop community partnerships and…
Headline
Laws that allow pharmacists to dispense the opioid antidote naloxone without a physician’s prescription are associated with a sharp reduction in fatal opioid-…
Headline
The White House Office of National Drug Control Policy seeks by 2022 to reduce drug overdose deaths and youth illicit drug use by 15 percent and opioid…
Perspective
Investing in our country’s health infrastructure is the right move to make.
Headline
The AHA yesterday announced support for the Opioid Workforce Act of 2019, bipartisan legislation to reduce the nation’s shortage of opioid treatment providers…